Back to Top
Narsoplimab Biosimilar - Research Grade
$710.00 - $6,900.00
Narsoplimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
MASP2ï؟½
Concentration
5mg/ml
Isotype
IgG4 - lambda2
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
O00187
Shipping Conditions
Blue ice
Background
MASP-2 is the key serine protease of the lectin complement pathway, initiating downstream activation and serving as a focal point in complement and inflammation research. This recombinant human IgG4 lambda2 antibody is an unconjugated, non-therapeutic analog of narsoplimab directed against MASP2 and supplied for research use only (RUO). Its low-endotoxin formulation supports in vivo studies, and production in scalable milligram (mg) to gram (g) quantities serves the needs of heavy-usage laboratories. The reagent is applied as a pathway-inhibition control and active tool in complement functional assays, in vitro screening, and preclinical models of complement-driven injury.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













